Endovia Health Sciences, Inc.
EDVA· NYSE
Filed May 9, 2013 · 10-Q · 39 days after period end · 0001079974-13-000236
| Metric | Q1 2013 | Q1 2012 |
|---|---|---|
| Revenue | $73.35K | $76.26K |
| Net Income | -$6.17K | -$14.06K |
| EPS Diluted | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Endovia Health Sciences, Inc. · CIK 1553788 · Engraved from SEC EDGAR
ended Mar 31, 2013 · filed May 9, 2013 · 39 d after period end